Identification of food-derived bioactive peptides in blood and other biological samples.
Recent studies have demonstrated the presence of food-derived peptides in human blood after ingestion of enzymatic hydrolysates of food proteins, while most peptides in food are degraded into amino acids during digestion and absorption. To capture and clarify the food-derived peptides in blood, solid-phase extraction (SPE) using a mini-spin...

MaxCyte is a Featured Speaker at 2nd International Stem Cells and Regenerative Medicine 2007.
'Engineering Cells for Clinical Regenerative Applications: A Practical Approach' GAITHERSBURG, Md., Jan. 16 /PRNewswire/ -- MaxCyte, Inc., a clinical stage therapeutic company and pioneer in non-viral cell loading systems, announces Joseph Fratantoni, M.D. will be a featured speaker at the 2nd International Stem Cells and Regenerative Medicine...

FDA inspections and recalls down in FY '06.
ATLANTA -- FDA performed 17,641 foreign and domestic inspections for all products in fiscal year 2006, compared to 19,803 in 2006 and 21,805 in 2004--a trend that may lead to criticism and oversight by the new Democratic Congress, whose leaders feel the agency has been too lax in enforcement....

Evaluation of the effect of aqueous extract of Croton urucurana Baillon (Euphorbiaceae) on the hemorrhagic activity induced by the venom of Bothrops jararaca, using new techniques to quantify hemorrhagic activity in rat skin.
Abstract Aqueous extracts of Croton urucurana (Sangra D'agua), a plant popularly considered a cicatrizant, were analyzed for anti-Bothrops jararaca venom activity. The plant extracts antagonized the hemorrhagic activity of the venom and proanthocyanidins were involved in this activity. Two new methods for the quantification of hemorrhagic activity...

Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement.
GAITHERSBURG, Md. and ATLANTA, Feb 4 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, and Expression Therapeutics, a biotechnology company specializing in factor VIII-based therapeutics, today announced a collaborative agreement to co-develop novel cell and protein therapies for Hemophilia...

Regional Anesthesia Eases Wounded Soldiers' Pain in Iraq and Afghanistan.
Untended Care Priorities May Contribute to PTSD and Increased Pain HONOLULU, Jan. 29 /PRNewswire/ -- Body armor, rapid transport, and artificial blood products have exponentially improved care and survival for soldiers during the wars in Iraq and Afghanistan. However, the treatment of their pain during medical transit...

Haemacure to Present at the 11th Annual BIO CEO & Investor Conference.
TSX: HAE MONTREAL, Feb. 3 /PRNewswire-FirstCall/ -- Haemacure Corporation (TSX: HAE) announced today that Joseph Galli, Chairman and Chief Executive Officer of Haemacure will present at the BIO CEO & Investor Conference, being held February 9-10 at the Waldorf-Astoria in New York City. Mr. Galli will present...

Biotest Pharmaceuticals Corporation Acquires Santa Fe, New Mexico Plasmapheresis Center.
BOCA RATON, Fla., Feb. 11 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a wholly owned subsidiary of Biotest AG, Dreieich, Germany, announced that it has acquired a plasma collection facility located at 2860 Cerrillos Road, Santa Fe, New Mexico from Talecris Plasma Resources, Inc. With this acquisition, BPC now operates...

Global Med Technologies(R) Licenses Multi-System Solution to One of Top Ten U.S. Donor Centers.
South Texas Blood & Tissue Center to Implement 3 Integrated Donor Systems DENVER, Jan. 27 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (BULLETIN BOARD: GLOB) , an international e-Health, medical information technology company, today announced that its Wyndgate Technologies(R) division has licensed its...

Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives.
RhoGAM(R) Brand Hailed as One of the Top Achievements in 50 Years of Women's Health RARITAN, N.J., Feb. 9 /PRNewswire/ -- RhoGAM(R) Brand, the original Rh immune globulin product, celebrates its 40th year in the marketplace helping Rh-negative women in the prevention of Hemolytic Disease of the...